MX385912B - Metodo de terapia fotodinamica (pdt) para el cancer de vejiga - Google Patents

Metodo de terapia fotodinamica (pdt) para el cancer de vejiga

Info

Publication number
MX385912B
MX385912B MX2018007166A MX2018007166A MX385912B MX 385912 B MX385912 B MX 385912B MX 2018007166 A MX2018007166 A MX 2018007166A MX 2018007166 A MX2018007166 A MX 2018007166A MX 385912 B MX385912 B MX 385912B
Authority
MX
Mexico
Prior art keywords
bladder cancer
photodynamic therapy
pdt
bladder
treatment
Prior art date
Application number
MX2018007166A
Other languages
English (en)
Spanish (es)
Inventor
Aslak Godal
Kjetil Hestdal
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of MX385912B publication Critical patent/MX385912B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B1/00Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
    • A61B1/307Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor for the urinary organs, e.g. urethroscopes, cystoscopes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/00615-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • A61N5/0603Apparatus for use inside the body for treatment of body cavities
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0601Apparatus for use inside the body
    • A61N5/0603Apparatus for use inside the body for treatment of body cavities
    • A61N2005/061Bladder and/or urethra
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light
    • A61N2005/0663Coloured light

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Radiation-Therapy Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
MX2018007166A 2015-12-17 2016-12-19 Metodo de terapia fotodinamica (pdt) para el cancer de vejiga MX385912B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15200938 2015-12-17
PCT/EP2016/081809 WO2017103285A1 (en) 2015-12-17 2016-12-19 Method of photodynamic therapy (pdt) for bladder cancer

Publications (1)

Publication Number Publication Date
MX385912B true MX385912B (es) 2025-03-18

Family

ID=55066354

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018007166A MX385912B (es) 2015-12-17 2016-12-19 Metodo de terapia fotodinamica (pdt) para el cancer de vejiga

Country Status (18)

Country Link
US (2) US11235168B2 (enExample)
EP (1) EP3389716B1 (enExample)
JP (1) JP6995755B2 (enExample)
KR (1) KR102787192B1 (enExample)
CN (2) CN119345612A (enExample)
AU (1) AU2016372575B2 (enExample)
BR (1) BR112018011965A2 (enExample)
CA (1) CA3008552C (enExample)
CL (1) CL2018001612A1 (enExample)
DK (1) DK3389716T3 (enExample)
ES (1) ES2910034T3 (enExample)
IL (1) IL259925B (enExample)
MX (1) MX385912B (enExample)
PL (1) PL3389716T3 (enExample)
RU (1) RU2745194C2 (enExample)
SG (1) SG11201805000RA (enExample)
WO (1) WO2017103285A1 (enExample)
ZA (1) ZA201804530B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016372575B2 (en) * 2015-12-17 2022-12-08 Photocure Asa Method of photodynamic therapy (PDT) for bladder cancer
CN110420326A (zh) * 2019-09-17 2019-11-08 上海复旦张江生物医药股份有限公司 一种多替泊芬的应用
KR20240011794A (ko) * 2021-08-17 2024-01-26 보스톤 싸이엔티픽 싸이메드 인코포레이티드 광활성제의 활성화를 위한 디바이스, 시스템 및 방법
AU2024231397A1 (en) 2023-03-07 2025-09-25 Photocure Asa Therapy for bladder cancer

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ291132B6 (cs) 1995-03-10 2002-12-11 Photocure Asa Estery kyselin 5-aminolevulových a farmaceutický prostředek s jejich obsahem
US7530461B2 (en) 1995-03-10 2009-05-12 Photocure Asa Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
US20050003154A1 (en) * 2002-12-13 2005-01-06 White Gary L. Laminated building panels having preselected colors
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0700580D0 (en) 2007-01-11 2007-02-21 Photocure Asa Use
GB0724279D0 (en) 2007-12-12 2008-01-23 Photocure Asa Use
CN101891639A (zh) * 2009-05-20 2010-11-24 上海先导化学有限公司 一种制备5-氨基酮戊酸盐酸盐的方法
CN102458388B (zh) 2009-06-11 2016-09-28 光治疗Asa公司 半固体组合物及药物制品
CN102802612A (zh) 2009-06-11 2012-11-28 光治疗Asa公司 含有5-氨基酮戊酸的固态组合物
RU2448745C2 (ru) * 2010-05-31 2012-04-27 Олег Феликсович Каган Способ лечения поверхностного рака мочевого пузыря
EP2793679B1 (en) * 2011-12-19 2017-05-17 Technical University of Denmark An illumination system for endoscopic applications
WO2014020164A1 (en) * 2012-08-03 2014-02-06 Photocure Asa Compounds
GB201221123D0 (en) * 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
AU2016372575B2 (en) * 2015-12-17 2022-12-08 Photocure Asa Method of photodynamic therapy (PDT) for bladder cancer

Also Published As

Publication number Publication date
JP2019501161A (ja) 2019-01-17
KR20180094986A (ko) 2018-08-24
BR112018011965A2 (pt) 2018-12-04
KR102787192B1 (ko) 2025-03-25
ES2910034T3 (es) 2022-05-11
US20220152411A1 (en) 2022-05-19
US11235168B2 (en) 2022-02-01
EP3389716B1 (en) 2022-03-23
RU2745194C2 (ru) 2021-03-22
CN119345612A (zh) 2025-01-24
US20190022404A1 (en) 2019-01-24
AU2016372575A1 (en) 2018-07-12
NZ743697A (en) 2024-10-25
ZA201804530B (en) 2019-09-25
IL259925A (en) 2018-07-31
CN108697800A (zh) 2018-10-23
DK3389716T3 (da) 2022-04-11
RU2018123834A3 (enExample) 2020-04-13
EP3389716A1 (en) 2018-10-24
SG11201805000RA (en) 2018-07-30
WO2017103285A1 (en) 2017-06-22
PL3389716T3 (pl) 2022-06-20
AU2016372575B2 (en) 2022-12-08
CL2018001612A1 (es) 2019-01-11
CA3008552C (en) 2024-01-02
US11980772B2 (en) 2024-05-14
RU2018123834A (ru) 2020-01-17
CA3008552A1 (en) 2017-06-22
IL259925B (en) 2022-04-01
JP6995755B2 (ja) 2022-01-17

Similar Documents

Publication Publication Date Title
WO2018089669A3 (en) Immunotherapeutic tumor treatment method
MX2021013830A (es) Inhibidores de ezh2 para tratar linfomas.
WO2016133903A3 (en) Combination therapy for cancer treatment
WO2016025635A3 (en) Combination therapy for treating cancer
WO2017053889A3 (en) Flt3 directed car cells for immunotherapy
EA201890146A1 (ru) СПОСОБЫ ЛЕЧЕНИЯ СОЛИДНЫХ ОПУХОЛЕЙ С ИСПОЛЬЗОВАНИЕМ КОМБИНИРОВАННОЙ ТЕРАПИИ ИНГИБИТОРОМ mTOR В ВИДЕ НАНОЧАСТИЦ
MX2017014338A (es) Seleccion dirigida de pacientes para el tratamiento con derivados de cortistatina.
MX2015011296A (es) Dispositivo foto-terapeutico, metodo y uso.
SG10201902664RA (en) Combination therapy for treating cancer
MX2020008906A (es) Compuestos con actividad inductora de ferroptosis y métodos de uso de estos.
CL2021002669A1 (es) (divisional de solicitud 3443-2018) tratamientos de cancer.
MX382162B (es) Combinaciones farmacéuticas de un inhibidor de enzima hdac con un inhibidor de proteasoma, y su uso en el tratamiento de cáncer.
WO2016043874A3 (en) Combination therapy for treating cancer
SG10201909199PA (en) Method for treating cancer
NZ630367A (en) Methods of treatment of pediatric solid tumor
TW201613578A (en) Pharmaceutical combinations
PH12016502352A1 (en) Pharmaceutical composition
HK1219689A1 (zh) 光疗装置、方法和用途
PH12020550462A1 (en) Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same
MX385912B (es) Metodo de terapia fotodinamica (pdt) para el cancer de vejiga
MX2020001727A (es) Terapia de combinacion.
PH12019500758A1 (en) Pharmaceutical compositions and methods for the treatment of cancer
PH12021551235A1 (en) Elacestrant in combination with abemaciclib in women with breast cancer
MY197664A (en) Immunity enhancing agent for cancer by allergin-1 antagonist
MY197942A (en) Adjuvant therapy for use in prostate cancer treatment